IDEXX Laboratories, Inc. (IDXX)

IDEXX Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	288.27	453.93	112.55	144.45	383.93
Cash & Short-Term Investments	288.27	453.93	112.55	144.45	383.93
Cash Growth	-36.50%	303.33%	-22.09%	-62.37%	325.05%
Accounts Receivable	473.58	512.56	442.47	406.12	355.27
Other Receivables	-	16.97	48.43	19.46	19.48
Receivables	473.58	529.53	490.9	425.58	374.74
Inventory	381.88	380.28	367.82	269.03	209.87
Prepaid Expenses	-	48.37	41.74	42	34.56
Other Current Assets	256.18	83.14	88.46	74.59	59.64
Total Current Assets	1,400	1,495	1,101	955.66	1,063
Property, Plant & Equipment	713.12	817.68	768.09	692.77	646.34
Long-Term Investments	-	30.25	30.25	5.25	-
Goodwill	-	365.96	361.8	359.35	243.35
Other Intangible Assets	-	84.5	97.67	99.04	52.54
Long-Term Accounts Receivable	-	167.96	148.97	122.16	91.68
Long-Term Deferred Tax Assets	-	107.36	55.22	24.78	31.55
Long-Term Deferred Charges	-	-	-	122.41	116.09
Other Long-Term Assets	1,180	190.96	183.29	55.8	50.28
Total Assets	3,293	3,260	2,747	2,437	2,295
Accounts Payable	114.21	110.64	110.22	116.14	74.56
Accrued Expenses	502.12	372.36	364.69	395.77	342.87
Short-Term Debt	250	250	579	73.5	-
Current Portion of Long-Term Debt	167.79	75	74.98	75	49.99
Current Portion of Leases	-	19.8	20.43	19.93	17.73
Current Income Taxes Payable	-	86.55	48.55	42.61	42.68
Current Unearned Revenue	33.8	37.2	37.94	40.03	42.57
Other Current Liabilities	-	-	-	0.6	12.37
Total Current Liabilities	1,068	951.55	1,236	763.58	582.76
Long-Term Debt	449.79	622.88	694.39	775.21	858.49
Long-Term Leases	-	99.67	101.24	87.38	77.04
Long-Term Unearned Revenue	-	28.53	30.86	41.17	46.16
Long-Term Deferred Tax Liabilities	-	7.24	8.15	8.94	11.71
Other Long-Term Liabilities	180.43	65.53	67.59	70.94	85.6
Total Liabilities	1,698	1,775	2,138	1,747	1,662
Common Stock	1,595	10.75	10.72	10.69	10.65
Additional Paid-In Capital	-	1,570	1,463	1,377	1,295
Retained Earnings	-	4,445	3,600	2,920	2,176
Treasury Stock	-	-4,475	-4,392	-3,571	-2,800
Comprehensive Income & Other	-	-65.68	-72.61	-47.77	-49.11
Total Common Equity	1,595	1,485	608.74	689.99	632.09
Minority Interest	-	-	-	-	0.71
Shareholders' Equity	1,595	1,485	608.74	689.99	632.8
Total Liabilities & Equity	3,293	3,260	2,747	2,437	2,295
Total Debt	867.57	1,067	1,470	1,031	1,003
Net Cash (Debt)	-579.31	-613.42	-1,357	-886.56	-619.32
Net Cash Per Share	-6.96	-7.30	-16.05	-10.24	-7.14
Filing Date Shares Outstanding	81.85	83.09	82.9	84.25	85.43
Total Common Shares Outstanding	81.85	83.03	82.89	84.56	85.45
Working Capital	331.98	543.71	-134.33	192.08	479.98
Book Value Per Share	19.49	17.88	7.34	8.16	7.40
Tangible Book Value	1,595	1,034	149.27	231.61	336.2
Tangible Book Value Per Share	19.49	12.45	1.80	2.74	3.93
Land	-	22.4	22.22	22.64	13.98
Buildings	-	432.04	356.05	329.09	319.38
Machinery	-	837.15	772.56	728.74	686.49
Construction In Progress	-	79.06	97.31	62.34	39.76
Leasehold Improvements	-	116.35	107.25	93.25	82.46

Source: S&P Capital IQ. Standard template. Financial Sources.